04/12/2024
4:28 PM | Black Diamond Therapeutics (Issuer)
Raman Prakash (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/12/2024
4:29 PM | Black Diamond Therapeutics (Issuer)
Campbell Shannon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/12/2024
4:27 PM | Black Diamond Therapeutics (Issuer)
Raman Prakash (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/12/2024
4:27 PM | Black Diamond Therapeutics (Issuer)
Campbell Shannon (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/12/2024
3:48 PM | Black Diamond Therapeutics (Filer)
| Form PRE 14A | |
04/11/2024
7:03 AM | Black Diamond Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/03/2024
8:00 PM | Behbahani Ali (Reporting)
Black Diamond Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
04/03/2024
7:49 PM | Black Diamond Therapeutics (Issuer)
DIXON WENDY L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
7:01 AM | Black Diamond Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/12/2024
6:17 AM | Black Diamond Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/12/2024
6:20 AM | Black Diamond Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/11/2024
12:14 PM | Black Diamond Therapeutics (Subject)
T. Rowe Price Investment Management, Inc. (Filed by)
| Form SC 13G/A | |
02/15/2024
4:45 PM | Black Diamond Therapeutics (Issuer)
Ni Fang (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
4:34 PM | Black Diamond Therapeutics (Issuer)
Jones Erika (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
4:35 PM | Black Diamond Therapeutics (Issuer)
Velleca Mark A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
4:36 PM | Black Diamond Therapeutics (Issuer)
Buck Elizabeth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
4:37 PM | Black Diamond Therapeutics (Issuer)
Yurasov Sergey (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
4:38 PM | Black Diamond Therapeutics (Issuer)
Hatzis-Schoch Brent (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
5:05 AM | BB BIOTECH AG (Filed by)
Black Diamond Therapeutics (Subject)
| Form SC 13G/A | |
01/04/2024
7:07 AM | Black Diamond Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/15/2023
3:48 PM | Behbahani Ali (Reporting)
Black Diamond Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/15/2023
3:40 PM | Black Diamond Therapeutics (Issuer)
DIXON WENDY L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2023
6:08 AM | Black Diamond Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/09/2023
4:24 PM | Black Diamond Therapeutics (Subject)
Versant Venture Capital VI, L.P. (Filed by)
| Form SC 13D/A | |
11/06/2023
6:14 AM | Black Diamond Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/06/2023
6:10 AM | Black Diamond Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/19/2023
2:08 PM | BB BIOTECH AG (Reporting)
BIOTECH GROWTH N V (Reporting)
Black Diamond Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2023
4:34 PM | Behbahani Ali (Reporting)
Black Diamond Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2023
4:25 PM | Black Diamond Therapeutics (Issuer)
DIXON WENDY L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2023
4:26 PM | Black Diamond Therapeutics (Issuer)
Velleca Mark A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2023
6:12 AM | Black Diamond Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/11/2023
6:26 AM | Black Diamond Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/11/2023
6:22 AM | Black Diamond Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/07/2023
3:30 PM | Black Diamond Therapeutics (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund, L.P. (Reporting)
Shah Rajeev M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/06/2023
3:45 PM | Behbahani Ali (Reporting)
Black Diamond Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2023
2:36 PM | BB BIOTECH AG (Reporting)
BIOTECH GROWTH N V (Reporting)
Black Diamond Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/29/2023
12:37 PM | BB BIOTECH AG (Reporting)
BIOTECH GROWTH N V (Reporting)
Black Diamond Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/29/2023
5:02 AM | Black Diamond Therapeutics (Filer)
| Form 424B5 | |
06/27/2023
2:52 PM | Black Diamond Therapeutics (Subject)
Epstein David M. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/27/2023
6:11 AM | Black Diamond Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/16/2023
5:42 PM | Behbahani Ali (Reporting)
Black Diamond Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Biden’s $374B Giveaway Into This Sector (Ad) Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving
See what this $374B giveaway could mean for your retirement right here Click here for the full story |
06/16/2023
4:41 PM | Black Diamond Therapeutics (Issuer)
Velleca Mark A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
4:41 PM | Black Diamond Therapeutics (Issuer)
DIXON WENDY L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2023
8:09 PM | Black Diamond Therapeutics (Issuer)
Velleca Mark A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2023
8:10 PM | Black Diamond Therapeutics (Issuer)
Shah Rajeev M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2023
8:11 PM | Black Diamond Therapeutics (Issuer)
Mayweg Alexander (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2023
8:16 PM | Behbahani Ali (Reporting)
Black Diamond Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2023
8:06 PM | Black Diamond Therapeutics (Issuer)
Dhingra Kapil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2023
8:07 PM | Black Diamond Therapeutics (Issuer)
DIXON WENDY L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2023
8:08 PM | Black Diamond Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2023
8:08 PM | Black Diamond Therapeutics (Issuer)
Menzel Garry E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2023
4:26 PM | Black Diamond Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2023
6:45 AM | Black Diamond Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/09/2023
6:43 AM | Black Diamond Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
